(March 25, 2021, 1:02 PM EDT) -- SILVER SPRING, Md. — The Food and Drug Administration on March 24 required GlaxoSmithKline to add a warning to the label of the company’s Shingrix shingles vaccine to warn of an association between the vaccine and Guillain-Barre syndrome (GBS)....